Nestlé has completed the acquisition of Vitaflo, a Liverpool-based global provider of clinical nutritional products that has enjoyed double-digit growth in the order of 30% over the last three years. This strategic transaction allows Nestlé to enter the fast-growing global market for clinical nutrition products tailor-made for people with inherited metabolic disorders. This sector is growing rapidly, as improved diagnosis and screening enable increasing numbers of cases to be detected, and new advances in science demonstrate the benefits of specialised nutrition as an integral part of clinical management. Vitaflo has approximate annual sales of CHF 40m. The acquisition price isn’t disclosed.